FAKTOR-OPTIONSSCHEIN - MEDTRONIC Stock

Certificat

DE000SQ0XWD9

Market Closed - Deutsche Boerse AG 15:37:12 2024-07-01 EDT
0.25 EUR -16.67% Intraday chart for FAKTOR-OPTIONSSCHEIN - MEDTRONIC
Current month-16.67%
1 month-37.50%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-01 0.25 -16.67%
24-06-28 0.3 -3.23%
24-06-27 0.31 -6.06%
24-06-26 0.33 -2.94%
24-06-25 0.34 -8.11%

Delayed Quote Deutsche Boerse AG

Last update July 01, 2024 at 03:37 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SQ0XWD
ISINDE000SQ0XWD9
Date issued 2022-09-27
Strike 82.75 $
Maturity Unlimited
Parity 1 : 1
Emission price 10.25
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 15.66
Lowest since issue 0.25
Spread 0.01
Spread %3.70%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
77.12 USD
Average target price
94.02 USD
Spread / Average Target
+21.92%
Consensus